Site identity card

Amphia Ziekenhuis

Breda, The Netherlands
Share

Networks

Clinical Studies (1)

  • Huygens : Study aims to evaluate the clinical outcome, viral clearance, and incidence of resistance-associated mutations that emerged during therapy in a cohort of 245 ICPs with COVID-19 treated with casirivimab/imdevimab, sotrovimab, and tixagevimab/cilgavimab

Study Data

  • Adults
  • Elderly
  • Fragile population
  • Immunocompromised host
  • Hospital wide
  • Outpatient clinic
  • SARS-CoV-2
  • Acute COVID-19
  • Pharmacological intervention
  • Monoclonal antibodies
  • Sotrovimab
  • Tixagevimab/Cilgavimab
  • Casirivimab/Imdevimab

Other information

If you would like to contact the site, please email: ccb@ateneo.univr.it

The data is updated up to